Kejun Nan

4.1k total citations
42 papers, 791 citations indexed

About

Kejun Nan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Kejun Nan has authored 42 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Immunology. Recurrent topics in Kejun Nan's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Cancer Treatment and Pharmacology (4 papers). Kejun Nan is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Cancer Treatment and Pharmacology (4 papers). Kejun Nan collaborates with scholars based in China, United States and Australia. Kejun Nan's co-authors include Hui Guo, Tao Tian, Wenjuan Wang, Lili Han, Shuo Yu, Shanyong Yi, Tinghua Hu, Jing Wang, Xiaomin Kang and Yu Yao and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Kejun Nan

42 papers receiving 781 citations

Peers

Kejun Nan

ONCOL

IMMUN

PRM

Pindong Li China

F. Darío Cuello-Carrión Argentina

Shuming Sun China

Qijie Zhao China

Zhenfeng Guan China

Wenfeng Yu China

Haiping Jiang China

Katherine M. Bever United States

Wenge Lu United States

Pindong Li China

Kejun Nan

340 ×1.0

130 ×0.4

ONCOL

169 ×0.9

89 ×0.6

IMMUN

77 ×0.6

PRM

Citations per year, relative to Kejun Nan Kejun Nan (= 1×) peers Pindong Li

Countries citing papers authored by Kejun Nan

Since Specialization

Citations

This map shows the geographic impact of Kejun Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kejun Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kejun Nan more than expected).

Fields of papers citing papers by Kejun Nan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kejun Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kejun Nan. The network helps show where Kejun Nan may publish in the future.

Co-authorship network of co-authors of Kejun Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Kejun Nan. A scholar is included among the top collaborators of Kejun Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kejun Nan. Kejun Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Qian, Ying Liu, Mingzhe Yan, et al.. (2024). Seasonal shifts in respiratory pathogen co-infections and the associated differential induction of cytokines in children. Cytokine. 186. 156847–156847. 1 indexed citations

Jiang, Panpan, Wenjuan Wang, Min Jiao, et al.. (2022). First-Line Chemotherapy Plus Immune Checkpoint Inhibitors or Bevacizumab in Advanced Non-Squamous Non-Small-Cell Lung Cancer without Egfr Mutations or Alk Fusions. Immunotherapy. 14(6). 445–457. 4 indexed citations

Qu, Di, et al.. (2019). Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy. Medical Oncology. 36(10). 84–84. 8 indexed citations

Lŭ, Lan, Zisong Zhou, Jian Liu, et al.. (2019). CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients. Genes. 10(11). 926–926. 37 indexed citations

Si, Xiaoyan, Li Zhang, Hanping Wang, et al.. (2019). Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303. Thoracic Cancer. 10(3). 551–556. 48 indexed citations

Zhang, Jianhua, et al.. (2017). Establishment of optimal regulatory network of colorectal cancer based on p42.3 protein. Saudi Journal of Biological Sciences. 24(8). 1781–1786. 6 indexed citations

Hu, Tinghua, Yu Yao, Shuo Yu, et al.. (2014). SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Cancer Letters. 354(2). 417–426. 119 indexed citations

Yi, Shanyong, et al.. (2014). New insights into metronomic chemotherapy-induced immunoregulation. Cancer Letters. 354(2). 220–226. 38 indexed citations

Wang, Mincong, Xuan Liang, Zhiyan Liu, et al.. (2014). In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non-small cell lung cancer cell lines. Oncology Reports. 33(1). 239–249. 20 indexed citations

10.

Yu, Yao, Shuo Yu, Lili Han, et al.. (2013). Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer. Journal of Biomedical Research. 27(4). 283–283. 34 indexed citations

11.

Zheng, Qi, et al.. (2013). CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line. World Journal of Surgical Oncology. 11(1). 5–5. 18 indexed citations

12.

Zheng, Qi, Yao Yu, & Kejun Nan. (2012). Weekly intravenous nanoparticle albumin-bound paclitaxel for elderly patients with stage IV non-small-cell lung cancer: a series of 20 cases. Journal of Biomedical Research. 26(3). 159–159. 7 indexed citations

13.

Zheng, Qi, et al.. (2010). [Hippocrates' viewpoint on cancer].. PubMed. 40(4). 234–6. 2 indexed citations

14.

Wang, Shuhong, Kejun Nan, & Yaochun Wang. (2009). Endothelial cells promote the proliferation of lymphocytes partly through the Wnt pathway via LEF-1. Biochemical and Biophysical Research Communications. 388(1). 67–72. 6 indexed citations

15.

Yi, Shanyong, et al.. (2008). [Effect of extract of Ginkgo biloba on doxorubicin-associated cardiotoxicity in patients with breast cancer].. PubMed. 28(1). 68–70. 9 indexed citations

16.

Nan, Kejun, et al.. (2008). Agents from amphibians with anticancer properties. Anti-Cancer Drugs. 19(10). 931–939. 77 indexed citations

17.

Nan, Kejun. (2008). Progress in research of estrogen receptor beta and primary liver cancer. 1 indexed citations

18.

Nan, Kejun. (2003). Randomized-controlled study of recombinant mutant human tumor necrosis factor in advanced malignant tumor. Zhongguo aizheng zazhi. 3 indexed citations

19.

Nan, Kejun. (2003). Prognostic factors in 165 elderly colorectal cancer patients. World Journal of Gastroenterology. 9(10). 2207–2207. 16 indexed citations

20.

Nan, Kejun. (2003). Cloning of human 15ku selenoprotein gene from H9 T cells. World Journal of Gastroenterology. 9(8). 1777–1777. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact